NCT00004654View on ClinicalTrials.gov

Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

January 31, 1996

Conditions

Hereditary Hemorrhagic Telangiectasia

Interventions

DRUG

soy protein isolate

All Listed Sponsors

collaborator

Yale University

OTHER

lead

National Center for Research Resources (NCRR)

NIH